Connect Biopharma Holdings Limited (CNTB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 50.93M | 77.76M | 96.96M | 115.9M | 122.55M | 19M | 22.75M | 29.55M | 43.2M | 50.18M | 24.78M | 52.64M |
| Cash & Short-Term Investments | 44.34M | 71.77M | 93.71M | 110.17M | 118.3M | 18.09M | 22.26M | 28.48M | 42.04M | 48.43M | 23.99M | 49.27M |
| Cash Only | 38.34M | 40.63M | 78.23M | 110.17M | 105.66M | 11.22M | 11.54M | 21.12M | 42.04M | 48.43M | 23.68M | 44.82M |
| Short-Term Investments | 6M | 31.14M | 15.48M | 0 | 12.64M | 6.87M | 10.72M | 7.36M | 0 | 0 | 306.41K | 4.44M |
| Accounts Receivable | 161K | 193K | 1.05M | 3.85M | 351K | 428.28K | 33.88K | 64.67K | 1.16M | 63.09K | 40.59K | 0 |
| Days Sales Outstanding | - | 1.18K | 320.22 | 7.94 | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.18M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 29K | 228K | 419K | 0 | 54K | 0 | 0 | 0 | -7.09M | 0 | 0 | 0 |
| Total Non-Current Assets | 5.15M | 4.97M | 4.32M | 4.67M | 4.82M | 812.23K | 2.66M | 5.52M | 2.5M | 1.81M | 658.17K | 1.42M |
| Property, Plant & Equipment | 4.46M | 4.88M | 4.24M | 4.52M | 4.74M | 701.92K | 785.35K | 1.56M | 1.48M | 614.01K | 184.49K | 496.45K |
| Fixed Asset Turnover | - | 0.01x | 0.16x | 5.21x | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 45K | 48K | 53K | 57K | 62K | 8.9K | 462.27K | 496.35K | 555.4K | 538K | 8.02K | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1.38M | 3.33M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 646K | 45K | 33K | 96K | 24K | 101.4K | 36.81K | 124.81K | 463.23K | 660.45K | 465.67K | 921.82K |
| Total Assets | 56.08M | 82.72M | 101.28M | 120.57M | 127.38M | 19.81M | 25.42M | 35.07M | 45.7M | 51.99M | 25.44M | 54.05M |
| Asset Turnover | - | 0.00x | 0.01x | 0.19x | - | - | - | - | - | - | - | - |
| Asset Growth % | -44.64% | -31.39% | -20.48% | 508.63% | 401.17% | -43.51% | -44.39% | -32.55% | 79.67% | - | -52.94% | - |
| Total Current Liabilities | 13.61M | 10.74M | 8.46M | 9.62M | 25.29M | 2.05M | 2.28M | 3.09M | 2.82M | 2.17M | 890.94K | 3.97M |
| Accounts Payable | 1.96M | 2.29M | 342K | 5.7M | 2.21M | 1.58M | 1.74M | 2.26M | 2M | 1.57M | 577.7K | 3.27M |
| Days Payables Outstanding | - | - | - | - | - | 299.95 | 346.63 | - | 395.22 | 442.54 | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 167K | 164K | 164K | 0 | 13.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.91M | 1.66M | 3.34M | 0 | 2.05M | 0 | 0 | 0 | -363.99K | 0 | 0 | 509.99K |
| Current Ratio | 3.74x | 7.24x | 11.46x | 12.04x | 4.85x | 9.26x | 9.97x | 9.58x | 15.30x | 23.15x | 27.81x | 13.24x |
| Quick Ratio | 3.74x | 7.24x | 11.46x | 12.04x | 4.85x | 9.26x | 9.97x | 9.58x | 15.30x | 23.15x | 27.81x | 12.44x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 482K | 642K | 656K | 467K | 585K | 66.67K | 131.01K | 157.27K | 127.19K | 11.53K | 48.58M | 93.35M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 368K | 520K | 24K | 73K | 180K | 44.35K | 35.78K | 50.05K | 4.08K | 11.53K | 7.25K | 67.17K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 114K | 122K | 632K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.57M | 91.9M |
| Total Liabilities | 14.1M | 11.38M | 9.12M | 10.09M | 25.88M | 2.12M | 2.41M | 3.24M | 2.95M | 2.18M | 49.47M | 97.33M |
| Total Debt | 690K | 870K | 178K | 325K | 465K | 81.7K | 62.95K | 83.84K | 19.63K | 26.24K | 21.41K | 127.96K |
| Net Debt | -37.66M | -39.76M | -78.05M | -109.85M | -105.2M | -11.14M | -11.48M | -21.04M | -42.02M | -48.41M | -23.66M | -44.7M |
| Debt / Equity | 0.02x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - |
| Debt / EBITDA | - | - | - | 0.02x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | -7.96x | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | 682.30x | -3435.41x | -2936.66x | -4585.92x | -7038.96x | - | - | - | -3172.79x |
| Total Equity | 41.98M | 71.34M | 92.17M | 110.48M | 101.5M | 17.69M | 23M | 31.83M | 42.75M | 49.81M | -24.03M | -43.27M |
| Equity Growth % | -54.45% | -35.42% | -9.19% | 524.51% | 341.24% | -44.41% | -46.19% | -36.11% | 277.89% | - | 44.47% | - |
| Book Value per Share | 0.75 | 1.29 | 1.67 | 1.99 | 1.84 | 0.32 | 0.42 | 0.58 | 0.80 | 1.06 | -0.44 | -0.78 |
| Total Shareholders' Equity | 41.98M | 71.34M | 92.17M | 110.48M | 101.5M | 17.69M | 23M | 31.83M | 42.75M | 49.81M | -24.03M | -43.27M |
| Common Stock | 10K | 10K | 10K | 10K | 10K | 1.25K | 1.46K | 1.47K | 1.57K | 1.58K | 563 | 3.05K |
| Retained Earnings | -400.83M | -368.53M | -345.36M | -531.7M | -329.73M | -64.45M | -70.08M | -61.88M | -56.8M | -48.17M | -25.12M | -42.38M |
| Treasury Stock | -180K | -180K | -180K | -180K | -180K | -22.15K | -26.29K | -25.91K | -28.26K | -72 | -70 | -144 |
| Accumulated OCI | -1.19M | -1.38M | -1.67M | -8.04M | -1.01M | 1.9M | -1.11M | 574.45K | -632.5K | -491K | -39.7K | -7.07M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |